S&P ASX All Technology

US Dollar vs AUD

Register for real-time alerts, custom portfolio, and market movers

Get Started

ARTL Artelo Biosciences Inc

1.28

-0.035 (-2.66%)

After Hours

Last Updated: 06:55:27

Delayed by 15 minutes

Artelo Biosciences EPS beats by $0.03

To read the full story on Seeking Alpha, click here.

Artelo Biosciences (NASDAQ:ARTL)
Historical Stock Chart
From Mar 2024 to Apr 2024

Click Here for more Artelo Biosciences Charts.

Artelo Biosciences (NASDAQ:ARTL)
Historical Stock Chart
From Apr 2023 to Apr 2024

Click Here for more Artelo Biosciences Charts.

Artelo Biosciences Inc News

Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update
Monday 25 March 2024 (3 weeks ago) • GlobeNewswire Inc.

Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation Challenge
Wednesday 13 March 2024 (1 month ago) • GlobeNewswire Inc.

Artelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12’s Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral Neuropathy
Wednesday 24 January 2024 (3 months ago) • GlobeNewswire Inc.

Artelo Biosciences Announces Selection of Worldwide Clinical Trials as Clinical Research Organization to Support First-in-Human Study of ART26.12
Tuesday 9 January 2024 (3 months ago) • GlobeNewswire Inc.

Artelo Biosciences Presents New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in Germany
Wednesday 6 December 2023 (4 months ago) • GlobeNewswire Inc.

Artelo Biosciences to Present Important New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in Germany
Friday 1 December 2023 (5 months ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 14 November 2023 (5 months ago) • Edgar (US Regulatory)

Artelo Biosciences Reports Third Quarter 2023 Financial Results and Provides Business Update
Tuesday 14 November 2023 (5 months ago) • GlobeNewswire Inc.

Artelo Biosciences Announces Publication of New Peer-Reviewed Research Demonstrating Protective Properties of ART27.13 Against Muscle Degeneration Caused by Certain Cancers
Friday 10 November 2023 (5 months ago) • GlobeNewswire Inc.

Artelo Biosciences to Present Preclinical Data Showcasing Research on ART26.12 and ART12.11 in Anxiety and Depression at Neuroscience 2023
Thursday 2 November 2023 (6 months ago) • GlobeNewswire Inc.

Principal Investigator of Artelo’s CAReS Trial to Participate in Medical Expert Webinar Hosted by H.C. Wainwright to Discuss Current Development Strategies for Cancer-Related Anorexia and Cachexia
Wednesday 4 October 2023 (6 months ago) • GlobeNewswire Inc.

Artelo Biosciences to Present at the 13th Congress of the European Pain Federation on September 20th
Wednesday 13 September 2023 (7 months ago) • GlobeNewswire Inc.

More Artelo Biosciences Inc News Articles

National Australia Bank

Commonwealth Bank Of Aus...

Verizon Communications

S&P ASX 300 Metals and M...

Westpac Banking

AUD vs US Dollar

Newcrest Mining

Woodside Petroleum

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions